CVS to pay $37.8 million to settle claims over insulin pens - Reuters

Reuters | Dec. 2, 2025, 11:39 a.m. | Original
CVS to pay $37.8 million to settle claims over insulin pens Reuters
Nvidia CFO says chipmaker yet to finalize $100 billion OpenAI deal - Reuters Fintech firm Wealthfront seeks up to $2.05 billion valuation in US IPO - Reuters